| Model Number |
TV-AB2980-N |
| Medical Device Problem Codes |
Material Puncture/Hole (1504); Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Aneurysm (1708); Failure of Implant (1924); Clinical Endoleak (4843)
|
| Date of Event |
10/21/2022
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
The device involved in this event will not be returned for evaluation as it remains implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by the clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Device remains implanted.
|
| |
|
Event or Problem Description
|
|
The patient was implanted with the alto stent graft system to treat an abdominal aortic aneurysm (aaa).Approximately one and a half (1.5) years post initial procedure a possible type 3b endoleak and sac growth were noted.The patient is currently being monitored while an intervention is being discussed.
|
| |
|
Additional Manufacturer Narrative
|
|
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the type 3b endoleak was with aneurysm enlargement are unconfirmed.The additional endovascular procedure (non endologix stent rcia) is confirmed.This is moderately consistent with the reported adverse event/incident.The clinical evaluation also shows reasonable evidence to suggest a type 2 endoleak of the lumbar artery (non-device related) occurred that was not included in the event as reported.The type 2 endoleak was discovered during the review of the ct scan dated (b)(6) 2022.Device, user, procedure or anatomy relatedness of this complaint could not be determined.No procedure related harms for this complaint were identified.The final patient status was reported to be discharged home on postoperative day three in stable condition.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Corrections: h6: investigation finding: remove code 3233.H6: investigation conclusion: remove code 11.
|
| |
|
Event or Problem Description
|
|
The patient was implanted with the alto stent graft system to treat an abdominal aortic aneurysm (aaa).Approximately one and a half (1.5) years post initial procedure a possible type 3b endoleak and sac growth were noted.The patient is currently being monitored while an intervention is being discussed.Additional information: an internal clinical evaluation shows reasonable evidence to suggest a type 2 endoleak of the lumbar artery (non-device related) occurred that was not included in the event as reported.The type 2 endoleak was discovered during the review of the ct scan dated (b)(6) 2022.
|
| |
|
Search Alerts/Recalls
|